Corvus Pharmaceuticals
CRVS
#8096
Rank
S$0.27 B
Marketcap
$4.00
Share price
-6.85%
Change (1 day)
69.53%
Change (1 year)

Earnings for Corvus Pharmaceuticals (CRVS)

Earnings in 2024 (TTM): -S$81.45 Million

According to Corvus Pharmaceuticals 's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -S$36.15 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corvus Pharmaceuticals from 2015 to 2024

Annual earnings

Year Earnings Change
2024 -S$83.32 Million130.47%
2023 -S$36.15 Million-34.57%
2022 -S$55.25 Million-4.47%
2021 -S$57.84 Million621.28%
2020 -S$8.02 Million-87.16%
2019 -S$62.42 Million-0.57%
2018 -S$62.78 Million-15.67%
2017 -S$74.45 Million53.03%
2016 -S$48.65 Million16.08%
2015 -S$41.91 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.2 Billion 129.39%๐Ÿ‡บ๐Ÿ‡ธ USA